The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy
- Conditions
- Pain, Postoperative
- Interventions
- Other: Placebo ODT
- Registration Number
- NCT04672252
- Lead Sponsor
- NYU Langone Health
- Brief Summary
This study is designed to evaluate the effects of administering CBD to control post-operative pain in patients undergoing shoulder arthroscopy. Secondly, the purpose will be to evaluate the effectiveness of CBD in comparison with opioid therapy for post-operative pain.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cohort 1 - CBD CBD Oral Disintegrating Tablet (ODT) - Cohort 2 - Placebo Placebo ODT -
- Primary Outcome Measures
Name Time Method Pain Visual Analog Scale (VAS) Score Day 14 Post-Surgery Pain severity scores at rest will be assessed by use of a visual analog scale (VAS; 0 = no pain, 10 = worst pain imaginable).
Nausea Score on VAS Scale Day 14 Post-Surgery Any nausea experienced by the patients will be recorded by use of a VAS (0 = no nausea, 10 = worst nausea imaginable).
- Secondary Outcome Measures
Name Time Method Number of Completed Doses Out of 3 Maximum Doses/Day Day 14 Post-Surgery Based on patient-self-report.
Total Opioid Consumption Day 14 Post-Surgery Consumption based on patient-self-report.
Patient Satisfaction Score Day 14 Post-Surgery Patients will record their satisfaction with their management, on a 0-10 scale (where 0= not at all satisfied; and 10 = completely satisfied).
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States